一例罕见的促甲状腺激素分泌型垂体腺瘤合并甲状腺乳头状癌以视力障碍为首发表现且无甲状腺功能亢进
本文报告一例57岁男性促甲状腺激素分泌型垂体腺瘤(TSHoma)合并分化型甲状腺癌(DTC)病例,以左眼颞侧偏盲就诊,无甲状腺功能亢进临床表现。影像发现鞍区及鞍上占位压迫视神经,游离甲状腺素与游离三碘甲状腺原氨酸轻度升高而促甲状腺激素在正常范围,术前诊断为TSHoma,甲状腺超声及111In-奥曲肽扫描发现左叶占位并经穿刺活检确诊甲状腺乳头状癌。围手术期给予短效奥曲肽预防甲状腺危象后行内镜经鼻经蝶手术切除肿瘤,病理确诊TSHoma,视力改善、甲状腺功能恢复正常,术后3个月行甲状腺切除术;作者同时复习了13例已报告的TSHoma合并DTC病例。
要点
- TSHoma患者多数有甲亢表现,本例无甲亢临床特征而以视力障碍起病。
- 鞍区占位伴游离甲状腺激素轻度升高而TSH正常时,应进一步行内分泌学检查以诊断TSHoma。
- TSHoma合并DTC的最佳治疗策略尚未确立,作者认为需要个体化治疗策略。
核心结论
- 作者报告首例以视力障碍起病、无任何甲亢临床特征的TSHoma合并DTC病例,并复习了13例已报告的TSHoma合并DTC病例。
- 作者指出TSHoma合并DTC患者的最佳治疗策略尚未确立,需要个体化的治疗策略。
研究设计与样本
- 个案报告:1例57岁男性TSHoma合并甲状腺乳头状癌患者,并复习文献中13例已报告的TSHoma合并DTC病例。
主要发现
- 患者57岁男性,表现为左眼颞侧偏盲,无任何甲亢体征;MRI显示鞍区及鞍上占位压迫视神经。
- 游离甲状腺素与游离三碘甲状腺原氨酸水平轻度升高,而血清促甲状腺激素水平保持在正常范围,进一步内分泌学检查作出TSHoma的术前诊断。
- 超声与111In-奥曲肽扫描显示甲状腺左叶占位,随后甲状腺穿刺活检确诊甲状腺乳头状癌。
- 围手术期给予短效奥曲肽以预防甲状腺危象后,经内镜经鼻经蝶手术切除肿瘤,病理诊断为TSHoma;患者视力改善,游离三碘甲状腺原氨酸与游离甲状腺素水平恢复正常。
- 患者在内镜经鼻经蝶手术3个月后接受甲状腺切除术。
临床怎么用
- 作者报告在给予短效奥曲肽预防围手术期甲状腺危象后行内镜经鼻经蝶手术切除肿瘤,患者于该手术后3个月行甲状腺切除术。
- 作者认为TSHoma合并DTC患者的最佳治疗策略尚未确立,需要个体化的治疗策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thyroid-stimulating hormone-secreting pituitary adenomas (TSHomas) are uncommon, and majority of the patients present with symptoms of hyperthyroidism. Herein, we report the first case of TSHoma with differentiated thyroid carcinoma (DTC) that presented with visual disturbance without any clinical feature of hyperthyroidism. CASE DESCRIPTION: A 57-year-old man presented with left temporal hemianopsia of his left eye without any sign of hyperthyroidism. A mass lesion in the sellar and suprasellar region compressing the optic nerves was identified via magnetic resonance imaging. Free thyroxine and free triiodothyronine levels were slightly elevated, whereas the serum level of thyroid-stimulating hormone remained within normal range. Further endocrinologic examination led to the preoperative diagnosis of TSHoma. Ultrasonography and 111In-octreotide scan showed a mass lesion in left lobe of the thyroid gland, and subsequent thyroid aspiration biopsy confirmed the diagnosis of papillary thyroid carcinoma. After administration of short-acting octreotide to prevent thyrotoxic crisis in the perioperative period, the tumor was removed via endoscopic transnasal-transsphenoidal surgery, and the pathologic diagnosis of TSHoma was made. His visual acuity improved, and free triiodothyronine and free thyroxine levels normalized. He underwent thyroidectomy 3 months later after endoscopic transnasal-transsphenoidal surgery. CONCLUSIONS: Herein, we report the first case of TSHoma with DTC that presented with visual disturbance without any clinical feature of hyperthyroidism and reviewed the 13 reported cases of TSHoma coexisting with DTC. The optimal treatment strategy in patients with TSHoma and coexistent DTC has not been established, and individualized therapeutic strategies are needed.
引用
- Inoue H, Shinojima N, Ueda R, et al. A Rare Case of Thyrotropin-Secreting Pituitary Adenoma Coexisting with Papillary Thyroid Carcinoma Presenting with Visual Disturbance without Hyperthyroidism. World Neurosurg. 2018. PMID: 30096503. doi:10.1016/j.wneu.2018.07.274
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。